Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.670
-0.025 (-3.60%)
At close: Apr 28, 2026
5.51%
Market Cap 148.75M
Revenue (ttm) 223.68M
Net Income (ttm) 14.16M
Shares Out 222.01M
EPS (ttm) 0.05
PE Ratio 14.24
Forward PE n/a
Dividend 0.03 (3.60%)
Ex-Dividend Date Jun 25, 2026
Volume 5,000
Average Volume 24,125
Open 0.670
Previous Close 0.695
Day's Range 0.670 - 0.670
52-Week Range 0.605 - 0.735
Beta 0.14
RSI 55.14
Earnings Date May 13, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu... [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 205
Stock Exchange Bursa Malaysia
Ticker Symbol RHONEMA
Full Company Profile

Financial Performance

In 2025, Rhone Ma Holdings Berhad's revenue was 223.68 million, an increase of 5.81% compared to the previous year's 211.41 million. Earnings were 14.16 million, an increase of 15.07%.

Financial Statements

News

There is no news available yet.